J&J | JNJ - Current Assets


J&J reported $59.17B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.53B 4.47B Mar/2026
Abbott USD 25.51B 488M Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Biogen USD 9.19B 216.3M Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
CONMED USD 670.59M 2.27M Mar/2026
Cooper Companies USD 2.3B 166M Mar/2026
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Eli Lilly USD 54.84B 794M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Intuitive Surgical USD 11.52B 881.5M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Merck USD 35.02B 8.5B Mar/2026
Merit Medical Systems USD 1.1B 61.62M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Regeneron Pharmaceuticals USD 18.21B 187.3M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026
Vertex Pharmaceuticals USD 11.73B 529.3M Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026
Zoetis USD 6.47B 294M Mar/2026